Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study

Published:2016 Issue:4 Volume:18 Page:3260-3271
ISSN:1463-9076
Container-title:Physical Chemistry Chemical Physics
language:en
Short-container-title:Phys. Chem. Chem. Phys.

Author:

Xue Weiwei¹²³⁴⁵,Wang Panpan¹²³⁴⁵,Li Bo¹²³⁴⁵,Li Yinghong¹²³⁴⁵,Xu Xiaofei¹²³⁴⁵,Yang Fengyuan¹²³⁴⁵,Yao Xiaojun⁶⁷⁸⁵,Chen Yu Zong⁹¹⁰¹¹¹²,Xu Feng¹³¹⁴¹⁵⁵,Zhu Feng¹²³⁴⁵

Affiliation:

1. Innovative Drug Research and Bioinformatics Group

2. Innovative Drug Research Centre and College of Chemistry and Chemical Engineering

3. Chongqing University

4. Chongqing 401331

5. China

6. State Key Laboratory of Applied Organic Chemistry and Department of Chemistry

7. Lanzhou University

8. Lanzhou 730000

9. Bioinformatics and Drug Design Group

10. Department of Pharmacy

11. National University of Singapore 117543

12. Singapore

13. College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research

14. Nankai University

15. Tianjin 300071

Abstract

The binding mode shared by 4 FDA approved SSRIs treating major depression was identified by integrating multiple computational methods.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Physical and Theoretical Chemistry,General Physics and Astronomy

Link

http://pubs.rsc.org/en/content/articlepdf/2016/CP/C5CP05771J

Reference70 articles.

1. Beyond genotype: serotonin transporter epigenetic modification predicts human brain function

2. Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today

3. Fluvoxamine rescues mitochondrial Ca2+ transport and ATP production through σ1-receptor in hypertrophic cardiomyocytes

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of selective serotonin reuptake inhibitors on weight loss after vertical sleeve gastrectomy;Surgery for Obesity and Related Diseases;2024-08

2. A Comprehensive Review of Analytical Methods Developed for Selective Serotonin Reuptake Inhibitors (SSRIs);Current Pharmaceutical Analysis;2024-07

3. CNSMolGen: A Bidirectional Recurrent Neural Network-Based Generative Model for De Novo Central Nervous System Drug Design;Journal of Chemical Information and Modeling;2024-05-13

4. Exploring novel lead scaffolds for SGLT2 inhibitors: Insights from machine learning and molecular dynamics simulations;International Journal of Biological Macromolecules;2024-04

5. The role of serotonin in depression—A historical roundup and future directions;Journal of Neurochemistry;2024-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3